NewGenIvf (NIVF) Gross Profit (2024 - 2025)

NewGenIvf (NIVF) posted quarterly Gross Profit of $524025.0 for Q4 2025, down 2.8% YoY from $539135.0 in Q4 2024, and up 344.03% sequentially from $118017.0 in Q3 2025.

NewGenIvf (NIVF) Gross Profit (2024 - 2025) Analysis & Trends

NewGenIvf has disclosed Gross Profit across 2 years of filings, most recently posting $524025.0 for Q4 2025.

  • In Q4 2025, Gross Profit fell 2.8% year-over-year to $524025.0; the TTM figure through Dec 2025 stood at $1.8 million (changed N/A YoY), while the FY2025 annual figure was $955846.0, down 47.68% from the prior year.
  • Gross Profit improved to $524025.0 in Q4 2025, from $118017.0 in the prior quarter.
  • Over the last five years, Gross Profit for NIVF reached as high as $649077.0 in Q3 2024 and fell as low as $118017.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 NewGenIvf 25,304.95 -1.41 Mn 524,025.00

Historic Data

Download Data
DateValue
Dec 31, 2025 524,025.00
Dec 31, 2025 524,025.00
Sep 30, 2025 118,017.00
Sep 30, 2025 118,017.00
Dec 31, 2024 539,135.00
Dec 31, 2024 539,135.00
Sep 30, 2024 649,077.00
Sep 30, 2024 649,077.00